HLA associations in type 1 diabetes among patients not carrying high-risk DR3-DQ2 or DR4-DQ8 haplotypes

Tissue Antigens

Volumn 54, Issue 6, 1999, Pages 543-551

  Undlien, Dag E ^a   Kockum, I ^b   Ronningen K S ^c   Lowe, R ^d   Saanjeevi, C B ^b   Graham, J ^d   Lie, B A ^a   Akselsen, H E ^a   Lernmark, A ^d   Thorsby, E ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Disease susceptibility; Genotype; HLA class II antigens; Insulin dependent diabetes mellitus; Transmission disequilibrium test (TDT)

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ARTICLE; CHROMOSOME 6; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE FREQUENCY; GENE LOCATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HAPLOTYPE; HISTOCOMPATIBILITY GENE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NORWAY; PRIORITY JOURNAL; SWEDEN;

COHORT STUDIES; DIABETES MELLITUS, TYPE 1; GENE EXPRESSION REGULATION; GENE FREQUENCY; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR3 ANTIGEN; HLA-DR4 ANTIGEN; HUMANS;

EID: 0033385183     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.1999.540602.x     Document Type: Article

References (38)

1. 1. Todd JA. Genetic analysis of type 1 diabetes using whole genome approaches. Proc Natl Acad Sci U S A 1995: 92: 8560-5.
2. 2. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 1987: 40: 1-1 4.
3. 3. Davies JL, Kawaguchi Y, Bennett ST et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994: 371: 130-6.
4. 4. She JX. Susceptibility to type 1 diabetes: HLA-DQ and DR revisited. Immunol Today 1996: 17: 323-9.
5. 5. Thorsby E, Undlien DE. The HLA associated predisposition to type 1 diabetes and other autoimmune diseases. J Ped Endocrinol Metabol 1996: 9: 75-88.
6. 6. Lie BA, Todd JA, Pociot F et al. The predisposition to type 1 diabetes linked to the HLA complex (IDDM1) includes at least one non-class II gene. Am J Hum Genet 1999: 64: 793-800.
7. 7. Cucca F, Muntoni F, Lampis R et al. Combinations of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia. Hum Immunol 1993: 37: 85-94.
8. 8. Caillat-Zucman S, Garchon HJ, Timsit J et al. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest 1992: 90: 2242-50.
9. 9. Van der Auwera B, Van Waeyenberge C, Schuit F et al. DRB1*0403 protects against IDDM in Caucasians with the high-risk heterozygous DQA1*0301-DQB1*0302/ DQA1*0501-DQB1*0201 genotype. Belgian Diabetes Registry. Diabetes 1995: 44: 527-30.
10. 10. Undlien DE, Friede T, Rammensee HG et al. HLA encoded genetic predisposition in insulin-dependent diabetes mellitus (IDDM). DR4 subtypes may be associated with different degrees of protection. Diabetes 1997: 46: 143-9.
11. 11. Sanjeevi CB, Lybrand TP, DeWeese C et al. Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of IDDM. Members of the Swedish Childhood Diabetes Study. Diabetes 1995: 44: 125-31.
12. 12. Ronningen KS, Spurkland A, Iwe T, Vartdal F, Thorsby E. Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens 1991: 37: 105-11.
13. 13. Dubois-Laforgue D, Timsit J, Djilali-Saiah I, Boitard C, Caillat-Zucman S. Insulin-dependent diabetes mellitus in non-DR3/ non-DR4 subjects. Hum Immunol 1997: 57: 104-9.
14. 14. Caillat-Zucman S, Djilali-Saiah I, Timsit J et al. Insulin dependent diabetes mellitus (IDDM): 12th International Histocompatibility Workshop study. In: Charron D, ed.. HLA. Genetic diversity of HLA. Functional and medical implication. Paris: EDK, 1997: 389-98.
15. 15. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993: 52: 506-16.
16. 16. Dahlquist G, Blom L, Tuvemo T, Nystrom L, Sandstrom A, Wall S. The Swedish childhood diabetes study - results from a nine year case register and a one year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders. Diabetologia 1989: 32: 2-6.
17. 17. Landin-Olsson M, Palmer JP, Lernmark A et al. Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children. Diabetologia 1992: 35: 1068-73.
18. 18. Ronningen KS, Spurkland A, Markussen G, Iwe T, Vartdal F, Thorsby E. Distribution of HLA class II alleles among Norwegian Caucasians. Hum Immunol 1990: 29: 275-81.
19. 19. Kockum I, Wassmuth R, Holmberg E, Michelsen B, Lernmark A. HLA-DQ primarily confers protection and HLA-DR susceptibility in type I (insulin-dependent) diabetes studied in population-based affected families and controls. Am J Hum Genet 1993: 53: 150-67.
20. 20. Bodmer JG, Marsh SG, Albert ED et al. Nomenclature for factors of the HLA system, 1996. Tissue Antigens 1997: 49: 321.
21. 21. Hagopian WA, Sanjeevi CB, Kockum I et al. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1995: 95: 1505-11.
22. 22. Tiwari JL, Terasaki P. The data and statistical analysis. In: Tiwari JL, Terasaki P, eds. HLA and disease associations. New York: Springer Verlag, 1985: 18-27.
23. 23. Payami H, Joe S, Farid NR et al. Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease. Am J Hum Genet 1989: 45: 541-6.
24. 24. Sham PC, Curtis D. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Ann Hum Genet 1995: 59: 323-36.
25. 25. Reijonen H, Ilonen J, Knip M, Akerblom HK. HLA-DQB1 alleles and absence of Asp 57 as susceptibility factors of IDDM in Finland. Diabetes 1991: 40: 1640-4.
26. 26. Undlien DE, Akselsen HE, Joner G et al. No difference in the parental origin of susceptibility HLA class II haplotypes among Norwegian patients with insulin-dependent diabetes mellitus. Am J Hum Genet 1995: 57: 1511-1.
27. 27. Ronningen KS, Gjertsen HA, Iwe T, Spurkland A, Hansen T, Thorsby E. Particular HLA-DQ alpha beta heterodimer associated with IDDM susceptibility in both DR4-DQw4 Japanese and DR4-DQw8/ DRw8-DQw4 whites. Diabetes 1991: 40: 759-63.
28. 28. Kawasaki E, Noble J, Erlich H, Mulgrew CL, Fain PR, Eisenbarth GS. Transmission of DQ haplotypes to patients with type 1 diabetes. Diabetes 1998: 47: 1971-3.
29. 29. Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987: 329: 599-604.
30. 30. Khalil I, d'Auriol L, Gobet M et al. A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest 1990: 85: 1315-9.
31. 31. Ronningen KS, Spurkland A, Tait BD et al. HLA class II associations in insulin-dependent diabetes mellitus among Blacks, Caucasoids and Japanese. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford: Oxford University Press, 1993: 713-22.
32. 32. Thorsby E, Ronningen KS. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993: 36: 371-7.
33. 33. Rammensee HG, Friede T, Stevanoviic S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995: 41: 178-228.
34. 34. Thorsby E. HLA associated diseases. Anniversary review article. Hum Immunol 1997: 53: 1-11.
35. 35. Cucca F, Lampis R, Frau F et al. The distribution of DR4 haplotypes in Sardinia suggests a primary association of type 1 diabetes with DRB1 and DQB1 loci. Hum Immunol 1995: 43: 301-8.
36. 36. Moller AM, Dalgaard LT, Pociot F, Nerup J, Hansen T, Pedersen O. Mutations in the hepatocyte nuclear factor-lalpha gene in Caucasian families originally classified as having Type I diabetes. Diabetologia 1998: 41: 1528-31.
37. 37. Erlich HA, Zeidler A, Chang J et al. HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat Genet 1993: 3: 358-64.
38. 38. Thomson G, Robinson WP, Kuhner MK et al. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet 1988: 43: 799-816.